血糖浓度检测技术的最新进展

本文阐述了血糖浓度检测技术的最新进展.从直接接触式的血糖浓度临床检测方法,以及市面上的各种微创式可随身携带的血糖浓度检测仪的测量技术,到近期正在研究的无创伤血糖浓度检测技术的描述,着重论述了目前国内外正在研究尚没应用于临床的无创伤血糖浓度检测的各种技术原理和方案,并对各种无创伤血糖浓度测量技术的工作原理和存在的临床应用问题进行分析,同时展望了血糖检测技术未来的发展之路.     

混浊介质后向散射特性的Mueller矩阵实验测量

Mueller矩阵是一种公认的能很好地表述介质偏振特性的方法.由于散射光偏振在生物组织无创伤诊断技术等诸多领域中的重要应用价值,对组织散射特性的Mueller矩阵的研究成为国际上组织光学的热点之一.与现有测量Mueller矩阵的实验方法相比,斜入射正接收装置用来测量Mueuer矩阵是一个更加行之有效的方法,再结合一种新的算法来处理后续数据,由此所获得的Mueller矩阵空间分布图的清晰度不亚于其它文献的报道.这种测量方法结构更简单,具有测量更方便、准确等优点.结果表明:入射角影响Mueller矩阵的空间分布图.随着介质浓度的增大,随机介质后向散射Mueller矩阵各元素的空间分布图样减小.     

Mueller矩阵在生物医学检测方面应用的实验研究

Mueller矩阵是公认的能很好地表述介质偏振特性的一种方法,由于散射光偏振在生物组织无创伤诊断技术等诸多领域中的重要应用价值,对组织散射特性的Mueller矩阵的研究成为国际上组织光学的热点之一。研究设计了一种新的测量Mueller矩阵的实验装置:斜入射正接收装置,并推导出一组后续数据处理的算法。由此所获得的Mueller矩阵空间分布图的清晰度不亚于其它所报道的,并且测量方法具有结构简单、方便、准确等优点。实验结果表明:入射角影响Mueller矩阵空间分布图;随着介质浓度的增大,随机介质后向散射Mueller矩阵各元素的空间分布图样减小;同时列举了真实生物组织样品(肌肉组织)的后向散射Mueller矩阵的实测结果,由此证明各向异性生物组织的后向散射Mueller矩阵各元素的空间分布图样与纤维的走向有关。     

生物组织光学特性的测量方法及医学应用

对生物组织光学特性参数的测量方法及其在医学上的应用进行了全面论述,分析了测量误差的来源,结果表明测量结果的客观性取决于模型假设（如散射的各向同性或异性、边界的匹配与否等）、测量技术、实验装置、定标方法和介质非均匀性等。测量方法可用于诊断生物组织的生理病理状态和测量组织结构     

生物组织折射率的概念与测量方法评述

折射率作为描述介质光学特性的一个重要物理参量,它在组织光学理论中起着非常重要的作用.随着组织光学研究的深入,生物组织折射率的概念也在不断地完善和发展.本文将主要介绍生物组织折射率的基本概念和测量手段的研究进展情况,明确了生物组织折射率的概念,评述了现有测量方法的优缺点,希望为生物组织折射率问题的进一步研究提供有益参考.     

一种微距测量组织光学参数的方法

测量生物组织的光学参数是近红外光学检测(NIR)的主要任务之一,然而常规的近红外光学检测由于受扩散近似的限制,测量的距离一般大于2cm-3cm。本文从提高近红外光学检测空间分辨率的角度,设计了一种可用于测量生物组织局部、浅表光学参数的方法。通过使用光纤探针,实现了在微小光源-探测器间距时(＜1mm)测量组织光学参数。模型实验的结果表明该方法可反映生物组织中吸收系数及散射系数的变化率。     

森林冠层地面叶面积指数光学测量方法研究进展

作为表征植被冠层结构的核心参数之一,叶面积指数（LAI）控制着植被冠层的多种生物物理和生理过程,如光合、呼吸、蒸腾、碳循环、降水截获、能量交换等.本文首先阐述了森林冠层地面LAI光学测量方法的理论基础和数学模型;其后介绍了目前主流光学测量方法的测量原理及其优缺点;归纳了LAI光学测量方法的主要误差来源（聚集效应、非光合作用组分、观测条件和地形效应）,并分析总结了聚集效应、非光合作用组分和地形效应的定量评估现状;最后展望了森林冠层地面LAI光学测量方法的未来发展方向.     

中国生理学会“生理机能实验发展方向实验室主任研讨班”通知

21世纪,不断提高科技人员的职业技能,加速培养高层次、复合型高素质人才是时代的迫切需要。实验生理科学课程面临着新的挑战,国外很多生命科学研究机构都将测量动物在清醒和无创伤性条件下的生理指标作为新技术、新方法研究的基础,因为这种更加真实的测量方法更符合于疾病本身的发展变化规律。应广大教学与科研工作者的要求,     

光动力治疗中光的有效吸收光剂量及其确定

光动力治疗中真正有效的光剂量是达到病变组织并且被组织中的光敏剂所吸收的那部分剂量,即有效吸收光剂量。明确组织中的有效吸收光剂量可以指导临床治疗,从而避免治疗剂量不足(治疗不彻底)或剂量过量(造成正常组织的热损伤)。而确定PDT中光的有效吸收剂量时,需测定组织中考察点的光辐射能流率。在目前计算和模拟组织中光辐射能流率的方法中,都需要首先确定所研究组织的光学特性参数。本文概述了常用的测定组织中光辐射能流率及组织光学特性参数的测量方法。     

生物阻抗技术概述

简要叙述了人体组织阻抗特性、生物阻抗技术的基本原理和测量方法,全面介绍了生物阻抗技术在细胞测量、体积测量、人体组织结构分析、组织监测、人体成分分析、生物阻抗成像等各方面的应用。     

In Vivo Blood Glucose Quantification Using Raman Spectroscopy

We here propose a novel Raman spectroscopy method that permits the noninvasive measurement of blood glucose concentration. To reduce the effects of the strong background signals produced by surrounding tissue and to obtain the fingerprint Raman lines formed by blood analytes, a laser was focused on the blood in vessels in the skin. The Raman spectra were collected transcutaneously. Characteristic peaks of glucose (1125 cm^-1) and hemoglobin (1549 cm^-1) were observed. Hemoglobin concentration served as an internal standard, and the ratio of the peaks that appeared at 1125 cm^-1 and 1549 cm^-1 peaks was used to calculate the concentration of blood glucose. We studied three mouse subjects whose blood glucose levels became elevated over a period of 2 hours using a glucose test assay. During the test, 25 Raman spectra were collected transcutaneously and glucose reference values were provided by a blood glucose meter. Results clearly showed the relationship between Raman intensity and concentration. The release curves were approximately linear with a correlation coefficient of 0.91. This noninvasive methodology may be useful for the study of blood glucose in vivo.     

Glucose determination by means of NMR spectrometry

NMR spectroscopy could be a method for non-invasive determination of glucose concentration in the future. In this connection, 13C-NMR spectroscopy is of special interest. In vitro investigation of blood serum samples in 13C-NMR revealed significant changes in signal intensities reflecting the different glucose concentrations in these samples. The further development of noninvasive in vivo glucose determination by means of NMR spectroscopy is closely associated with technological progress.     

PET脑血流量测量方法和临床应用进展

脑血流量测量对于脑血管疾病、脑肿瘤诊断和疗效评估具有重要的临床价值。PET是基于正电子示剂技术无创性、精确测量脑血流量的方法,正日益广泛地应用于临床。按照PET测量脑血流量的方法和使用的正电子示踪剂不同,其测量方法分为平衡法、放射自显影法和动力学方法三种。18O-H2O示踪剂PET测量脑血流量被认为测量脑血流方法的"金标准"。随着PET设备分辨率提高、新的图像重建方法使用和PET与MRI图像融合技术不断成熟,18F-FDG首次通过、采用图像衍生动脉输入函数(imagederived arterial input function,IDAIF)替代动脉抽血样精确测量脑血量方法受到广泛重视,有可能逐步取代高成本的18O-H2O测量脑血流量。PET无创、方便和精确测量脑血流量的方法在临床应使用有助于脑血管性疾病、脑肿瘤和脑退行性病变早期诊断、鉴别诊断和个性化医疗。本文介绍PET脑血流量测量原理、方法和临床应用进展。     

A viscosity-dependent affinity sensor for continuous monitoring of glucose in biological fluids

We present a viscometric affinity biosensor for continuous monitoring of glucose in biological fluids such as blood and plasma. The sensing principle of this chemico-mechanical sensor is based upon the viscosity variation of a sensitive fluid with glucose concentration. Basically, this device includes both an actuating and a sensing piezoelectric diaphragms as well as a flow-resistive microchannel. In order to confine the sensitive fluid and allow glucose diffusion into the sensor, a free-standing alumina nanoporous membrane is also used as size-selective interface. Measurements carried out at nominal temperatures of 25 and 37 °C reveal that this sensor topology exhibits a high resolution in the current range of physiological blood glucose concentrations, i.e. 2-20 mM. In addition, complete reversibility was also demonstrated for at least 3 days. Finally, measurements performed in human blood serum confirm that this sensor fulfils all basic requirements for a use in continuous glucose monitoring of biological fluids.     

Glucose gradient differences in subcutaneous tissue of healthy volunteers assessed with ultraslow microdialysis and a nanolitre glucose sensor

The abdominal subcutaneous interstitium is easily accessible for monitoring glucose for Diabetes Mellitus research and management. The available glucose sensing devices demand frequent blood sampling by finger pricking for calibration. Moreover, there is controversy about the exact relationship between the levels of glucose in the subcutis and blood. In the present study ultra-slow microdialysis was applied for subcutaneous fluid sampling, allowing continuous measurement of glucose in an equilibrated fluid using a nanolitre size sensor. The present method avoids in vivo calibration. During an oral glucose tolerance test glucose levels were measured simultaneously in blood, in adipose tissue and loose connective tissue layers of the abdominal subcutis in seven healthy subjects. Fasting glucose levels (mM) were 2.52 +/- 0.77 in adipose tissue and 4.67 +/- 0.17 in blood, this difference increasing to 6.40 +/- 1.57 and 11.59 +/- 1.52 at maximal glucose concentration. Moreover, the kinetics of glucose in blood and adipose tissue were different. In contrast, connective tissue glucose levels differed insignificantly (4.71 +/- 0.21 fasting and 11.70 +/- 1.96 at maximum) from those in blood and correlated well (r2 = 0.962). Ultra-slow microdialysis combined with a nanolitre glucose sensor could be of benefit to patients in intensive diabetes therapy. Frequent blood sampling for in vivo calibration can be avoided by monitoring glucose in the abdominal subcutaneous loose connective tissue, rather than in the adipose tissue.     

Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance

Noninvasive cardiac output (CO) measurement can be useful in many clinical settings where invasive monitoring is not desired. Bioimpedance (intrabeat measurement of changes in transthoracic voltage amplitude in response to an injected high-frequency current) has been explored for this purpose but is limited in some clinical settings because of inherently low signal-to-noise ratio. Since changes in fluid content also induce changes in thoracic capacitive and inductive properties, we tested whether a noninvasive CO measurement could be obtained through measurement of the relative phase shift of an injected current (i.e., bioreactance). We constructed a prototype device that applies a 75-kHz current and determines the relative phase shift (dPhi/dt) of the recorded transthoracic voltage. CO was related to the product of peak dPhi/dt, heart rate, and ventricular ejection time. The preclinical study was done in nine open-chest pigs put on right heart bypass so that CO could be varied at known values. This was followed by a feasibility study in 27 postoperative patients who had a Swan-Ganz catheter (SGC). The measurements of noninvasive CO measurement and cardiopulmonary bypass pump correlated to each other (r = 0.84) despite the large variation in CO and temperatures. Similarly, in patients, mean CO values were 5.18 and 5.17 l/min as measured by SGC and the noninvasive CO measurement system, respectively, and were highly correlated over the range of values studied (r = 0.90). Preclinical and clinical data demonstrate the feasibility of using blood flow-related phase shifts of transthoracic electric signals to perform noninvasive continuous CO monitoring.     

Amperometric glucose biosensor with extended concentration range utilizing complexation effect of borate.

Borate buffer strongly decreases amperometric response of a glucose oxidase linked pO2 or H2O2 sensing electrode, extending substantially its linear calibration range. With increasing pH and concentration of the buffer the upper limit for glucose can be varied between 1 and 30 mmol l-1 glucose. The effect of borate ion is explained by the rapid complexation of glucose decreasing the equilibrium concentration of free beta-anomer, the specific substrate of glucose oxidase. The high loading of cross-linked enzyme inside the sensor membrane is necessary for the measurement to ensure an almost constant response factor (delta i per 1 mmol l-1) between pH 5 and 10. Analysis in stirred solution and in a flow-through system has been employed for the measurement of elevated glucose levels in heparinized human blood or plasma samples.     

Multidimensional Mapping Method Using an Arrayed Sensing System for Cross-Reactivity Screening

When measuring chemical information in biological fluids, challenges of cross-reactivity arise, especially in sensing applications where no biological recognition elements exist. An understanding of the cross-reactions involved in these complex matrices is necessary to guide the design of appropriate sensing systems. This work presents a methodology for investigating cross-reactions in complex fluids. First, a systematic screening of matrix components is demonstrated in buffer-based solutions. Second, to account for the effect of the simultaneous presence of these species in complex samples, the responses of buffer-based simulated mixtures of these species were characterized using an arrayed sensing system. We demonstrate that the sensor array, consisting of electrochemical sensors with varying input parameters, generated differential responses that provide synergistic information of sample. By mapping the sensing array response onto multidimensional heat maps, characteristic signatures were compared across sensors in the array and across different matrices. Lastly, the arrayed sensing system was applied to complex biological samples to discern and match characteristic signatures between the simulated mixtures and the complex sample responses. As an example, this methodology was applied to screen interfering species relevant to the application of schizophrenia management. Specifically, blood serum measurement of antipsychotic clozapine and antioxidant species can provide useful information regarding therapeutic efficacy and psychiatric symptoms. This work proposes an investigational tool that can guide multi-analyte sensor design, chemometric modeling and biomarker discovery.     

Noninvasive in vivo glucose detection in human finger interstitial fluid using wavelength‐modulated differential photothermal radiometry

We present a noninvasive and noncontacting biosensor using Wavelength Modulated Differential Photothermal Radiometry (WM‐DPTR) to monitor blood glucose concentration (BGC) through interstitial fluid (ISF) probing in human middle fingers. WM‐DPTR works in the interference‐free mid‐infrared range with differential wavelengths at the peak and baseline of the fundamental glucose molecule absorption band, giving rise to high glucose sensitivity and specificity. In vivo WM‐DPTR measurements and simultaneous finger pricking BGC reference measurements were performed on diabetic and nondiabetic volunteers during oral glucose tolerance testing. The measurement results demonstrated high resolution and large dynamic range (~80 deg) change in phase signal in the normal‐to‐hyperglycemia BGC range (5 mmol/L to higher than 33.2 mmol/L), which were supported by negative control measurements. The immunity to temperature variation of WM‐DPTR yields precise and accurate noninvasive glucose measurements in the ISF.